Lonza sharpens pharma focus with CHF4.2B sale of Specialty Ingredients to Bain Capital and Cinven

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

12 May 2021 --- Taking place from May 10 to 13, Vitafoods Insights Virtual Expo is putting the spotlight on mental performance, immunity and mobility. NutritionInsight speaks... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

07 May 2021 --- In nutrition news this week, Milk Specialties Global began marketing its lactoferrin products after investing in its production capacity. Meanwhile, a series of... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 May 2021 --- Delivery formats, scientific backing and immunity are bound to shape the collagen space, according to industry experts. NutritionInsight discusses the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Apr 2021 --- Nootropics are one of the fastest-growing industry segments, according to a roundtable of experts from Mibelle, Finzelberg, Lubrizol Life Science, Health and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Apr 2021 --- Despite – or perhaps because of – the term’s vagueness, naturality demands have a significant presence in the nutrition sphere. They intersect... Read More

trans